HORIZON PHARMA INVT LTD's ticker is and the CUSIP is 44052TAB7. A total of 32 filers reported holding HORIZON PHARMA INVT LTD in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.4%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 90,100,000 | $83,284,000 | 3.21% |
| Lion Point Capital, LP | 16,000,000 | $14,560,000 | 2.13% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 42,250,000 | $38,448,000 | 2.11% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 52,956,000 | $48,618,000 | 0.91% |
| LINDEN ADVISORS LP | 25,106,000 | $22,975,000 | 0.85% |
| Jabre Capital Partners S.A. | 6,700,000 | $6,135,000 | 0.73% |
| Nicholas Investment Partners, LP | 11,085,000 | $10,087,000 | 0.71% |
| AQR Arbitrage LLC | 38,875,000 | $35,571,000 | 0.40% |
| SSI INVESTMENT MANAGEMENT LLC | 3,325,000 | $3,025,000 | 0.28% |
| PALISADE CAPITAL MANAGEMENT, LP | 6,278,000 | $5,766,000 | 0.22% |